SCHEMBL4905804

SCHEMBL4905804

O=CC1=CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7429303 0.85
SCHEMBL16381941 0.66
SCHEMBL1446770 0.65
SCHEMBL23662539 0.63 ALDH1A1 (0.40)
SCHEMBL8988313 0.58
SCHEMBL15010421 0.58
SCHEMBL2592232 0.57
SCHEMBL10472958 0.57
SCHEMBL9971051 0.57
SCHEMBL257414 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006399-B1 Polymer and polymer-derived particles comprising polyfurfuryl alcohol and methods thereof SILA NANOTECHNOLOGIES, INC. (US) 2024-06-11 US disclosed
US-20230365485-A1 PROCESS FOR PRODUCING LEVULINIC ACID BIO ON S.P.A. (IT) 2023-11-16 US disclosed
US-20230365485-A1 PROCESS FOR PRODUCING LEVULINIC ACID BIO ON S.P.A. (IT) 2023-11-16 US disclosed
WO-2021114207-A1 PRODUCTION OF BENZENE DERIVATIVES RHODIA OPERATIONS (FR) 2021-06-17 WO disclosed
WO-2020192570-A1 SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME 上海再极医药科技有限公司 2020-10-01 WO disclosed
CN-108203419-A The preparation method of Bu Waxitan intermediates 浙江京新药业股份有限公司 2018-06-26 CN disclosed
US-20170233364-A1 Versatile Non-Destructive Surface Modification of Carbonaceous Materials and Process for Grafting Into Polymer Matrices SOUTH DAKOTA BOARD OF REGENTS 2017-08-17 US disclosed
CN-103483307-A Preparation method of 4,5-dimethyl-1,3-dioxole-2-ketone LU AN KOREDA NEW MATERIAL CO LTD 2014-01-01 CN disclosed
US-8383859-B2 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia THADANI AVINASH N (CA) 2013-02-26 US disclosed
CN-102471300-A Compositions and methods for enhancing viral potency OTTAWA HOSPITAL RES INST 2012-05-23 CN disclosed
US-20110065159-A1 BIOMASS HYDROLYSIS UNITED STATES DEPARTMENT OF ENERGY 2011-03-17 US disclosed
CN-101932586-A Inhibition of protein tyrosine kinase activity METHYLGENE INC 2010-12-29 CN disclosed
US-20100174090-A1 METHODS OF PREPARING PRIMARY, SECONDARY AND TERTIARY CARBINAMINE COMPOUNDS IN THE PRESENCE OF AMMONIA THADANI AVINASH N 2010-07-08 US disclosed
EP-1984377-A2 INHIBITORS OF TNF ALPHA , PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH Signal Pharmaceuticals LLC (US) 2008-10-29 EP disclosed
US-20080004271-A1 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith MCKENNA JEFFREY M 2008-01-03 US disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed
CN-1034415-C Novel ascorbic acid derivatives MERRELL DOW PHARMA (US) 1997-04-02 CN disclosed
CN-1067653-A Novel herbicide RHONE POULENC AGRICULTURE (GB) 1993-01-06 CN disclosed
CN-1054978-A NOVEL ASCORBIC ACID DERIVATIVES MERRELL DOW PHARMA (US) 1991-10-02 CN disclosed